Holen Sie sich die Stockscreener-App
3.06
4.38%
-0.14
Handel nachbörslich:
3.02
-0.04
-1.31%
Schlusskurs vom Vortag:
$3.20
Offen:
$3.2
24-Stunden-Volumen:
40,967
Relative Volume:
0.46
Marktkapitalisierung:
$112.32M
Einnahmen:
$306.00K
Nettoeinkommen (Verlust:
$-36.24M
KGV:
-2.6379
EPS:
-1.16
Netto-Cashflow:
$-27.32M
1W Leistung:
-5.85%
1M Leistung:
-0.33%
6M Leistung:
-1.61%
1J Leistung:
-52.11%
1-Tages-Spanne:
$3.023
$3.25
1-Wochen-Bereich:
$3.023
$3.292
52-Wochen-Spanne:
$1.37
$9.1297
Sera Prognostics Inc Stock (SERA) Company Profile
Firmenname
Sera Prognostics Inc
Sektor
Branche
Telefon
(801) 990-0520
Adresse
2749 E. PARLEYS WAY, SALT LAKE CITY
Vergleichen Sie SERA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SERA
Sera Prognostics Inc
|
3.06 | 121.80M | 306.00K | -36.24M | -27.32M | -1.16 |
|
ABT
Abbott Laboratories
|
132.57 | 232.02B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
95.41 | 144.14B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.60 | 141.53B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.45 | 123.78B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.94 | 44.14B | 5.69B | 1.41B | 577.90M | 6.9828 |
Sera Prognostics Inc Stock (SERA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-03-30 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-11-19 | Eingeleitet | Oppenheimer | Outperform |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
Sera Prognostics Inc Aktie (SERA) Neueste Nachrichten
Pattern recognition hints at Sera Prognostics Inc. upsideBreakout Watch & Capital Efficient Trade Techniques - newser.com
How buybacks impact Sera Prognostics Inc. stock valueJuly 2025 Closing Moves & Proven Capital Preservation Tips - newser.com
How to use Fibonacci retracement on Sera Prognostics Inc.2025 Trade Ideas & AI Powered Market Entry Strategies - newser.com
What drives Sera Prognostics Inc stock priceBull Market Opportunities & Minimal Capital Growth Plans - earlytimes.in
Sera Prognostics (NASDAQ:SERA) Receives "Sell (D-)" Rating from Weiss Ratings - MarketBeat
Will Sera Prognostics Inc. continue its uptrendQuarterly Trade Report & Reliable Momentum Entry Alerts - newser.com
Published on: 2025-10-09 02:25:33 - newser.com
Published on: 2025-10-09 05:14:41 - earlytimes.in
Insider Sell: Robert Harrison Sells 2,000 Shares of Sera Prognos - GuruFocus
Sera prognostics CIO Harrison sells $6360 in stock By Investing.com - Investing.com Canada
What analysts say about Sera Prognostics Inc stockValue Stock Picks & High Profit Trading Signals - earlytimes.in
Identifying reversal signals in Sera Prognostics Inc.Weekly Stock Summary & High Conviction Buy Zone Picks - newser.com
What Fibonacci levels say about Sera Prognostics Inc. reboundTrade Exit Summary & AI Based Buy and Sell Signals - newser.com
Is Sera Prognostics Inc. stock cheap at current valuationJuly 2025 Institutional & Intraday High Probability Alerts - newser.com
Will a bounce in Sera Prognostics Inc. offer an exitPortfolio Value Summary & Weekly High Momentum Picks - newser.com
Should you wait for a breakout in Sera Prognostics Inc.July 2025 PreEarnings & Long-Term Capital Growth Strategies - newser.com
Tools to assess Sera Prognostics Inc.’s risk profileWeekly Gains Report & Smart Swing Trading Techniques - newser.com
Sera Prognostics appoints Dr. Tiffany Inglis as chief medical officer By Investing.com - Investing.com Nigeria
Sera Prognostics appoints Dr. Tiffany Inglis as chief medical officer - Investing.com
Women's Health Pioneer Sera Prognostics Taps OBGYN Leader Dr. Inglis to Drive PreTRM Test Adoption - Stock Titan
Detecting support and resistance levels for Sera Prognostics Inc.Weekly Investment Summary & AI Optimized Trading Strategy Guides - newser.com
Finanzdaten der Sera Prognostics Inc-Aktie (SERA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):